SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

QuotedData's Weekly News & Interview

26 Jan 2023 11:32

RNS Number : 9947N
RTW Venture Fund Limited
26 January 2023
 

QuotedData's Investment Trust Weekly News Round-up Show - Stephanie Sirota from RTW Venture Fund

On the 20th January, James Carthew talked through the Weekly News and interviewed Stephanie Sirota from RTW Venture Fund - Watch here.

About our Weekly Show:

The best way to enjoy the show is to join our weekly webinar live, at 11 am every Friday, where we discuss the key stories and events in the investment companies' sector over the last week. We also invite a guest every week and give you the opportunity to get answers to your questions.

Click here to view our previous recordings: https://quoteddata.com/events/?past=true

Click here to view our upcoming events: https://quoteddata.com/events/

This information is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. QuotedData is a trading name of Marten & Co Limited, which is authorised and regulated by the Financial Conduct Authority. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.

QUOTEDDATA50 Gresham Street | London | EC2V 7AY | UKTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABBGDBGXDDGXL
Date   Source Headline
1st Nov 20225:07 pmRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSQuarterly Update
20th Oct 20227:00 amRNSEdison issues review on RTW Venture Fund (RTW)
14th Oct 20227:00 amRNSNet Asset Value(s)
22nd Sep 20227:00 amRNSDirector/PDMR Shareholding
16th Sep 20227:00 amRNSPortfolio Company Update: Third Harmonic Bio IPO
15th Sep 20227:30 amRNSNet Asset Value(s)
15th Sep 20227:00 amRNSHalf-year Report
17th Aug 202212:00 pmRNSNotice of Interim Report
12th Aug 20227:00 amRNSNet Asset Value(s)
26th Jul 20227:00 amRNSQuarterly Update
19th Jul 20227:55 amRNSAdditional Investment in Portfolio Company
15th Jul 20227:00 amRNSNet Asset Value(s)
6th Jul 20227:00 amRNSPortfolio Company Transaction Update
21st Jun 20225:33 pmRNSResult of AGM
13th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNotice of AGM
13th May 20227:00 amRNSNet Asset Value(s)
28th Apr 20227:00 amRNSQuarterly Update
14th Apr 20227:05 amRNSNew Investment
14th Apr 20227:00 amRNSNet Asset Value(s)
4th Apr 20224:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:22 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Financial Report
14th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSNotice of Annual Report
17th Feb 20227:50 amRNSAdditional Investment in Magnolia Medical
16th Feb 202212:45 pmRNSNew Investment in Third Harmonic Bio
14th Feb 20227:00 amRNSNet Asset Value(s)
26th Jan 20222:00 pmRNSNew Investment in Kyverna
24th Jan 20227:00 amRNSQuarterly Update
14th Jan 20227:00 amRNSNet Asset Value(s)
12th Jan 20228:05 amEQSEdison Investment Research Limited: RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment
10th Jan 20227:00 amRNSPortfolio Company Update: CinCor Pharma IPO
14th Dec 20217:00 amRNSNet Asset Value(s)
12th Nov 20217:00 amRNSNet Asset Value(s)
26th Oct 20217:00 amRNSQuarterly Update
22nd Oct 20217:00 amRNSPortfolio Company Update: Ventyx IPO
14th Oct 20217:00 amRNSNet Asset Value(s)
13th Oct 20217:00 amRNSNew Investment in CinCor Pharma
11th Oct 20217:00 amRNSPortfolio Company Update: Pyxis IPO
1st Oct 20217:00 amRNSTotal Voting Rights
21st Sep 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20217:00 amRNSIssue of Equity
16th Sep 20215:48 pmRNSAnnouncement of Share Issuance
16th Sep 20217:00 amRNSHalf-year Report
15th Sep 20217:00 amRNSNet Asset Value(s)
9th Sep 202112:00 pmRNSNew Investment in Lycia
9th Sep 20217:00 amRNSNew Investment in InBrace
1st Sep 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.